In people with obesity, particularly in cases of rapid or marked weight reduction, the decline in lean mass may account up to 2530% of the total weight loss, contributing to the so-called sarcopenic obesity [18]
Here's What Dietitians Say Potential Risks of GLP-1 Agonists Although GLP-1 medications can be highly effective, they are not without some risks
The primary endpoint was a composite of death from cardiac causes, non-fatal acute myocardial infarction, and stroke
L-carnitine has a protective effect on the colonic mucosa during abdominopelvic radiotherapy in rats
2021 Dec;49(12):3000605211060675
A recent report from the Institute for Clinical and Economic Review, an independent nonprofit that evaluates the value of medical treatments, found that GLP-1s such as Ozempic, Wegovy and Zepbound are cost-effective, meaning the medication's health benefits justify their price